A federal judge tossed all the plaintiffs’ general causation experts in thousands of cases filed over heartburn medication Zantac.

Tuesday’s opinion, by U.S. District Judge Robin Rosenberg in West Palm Beach, Florida, effectively dismissed the Zantac multidistrict litigation, which involves about 50,000 claims. In 2020, the U.S. Food and Drug Administration announced an involuntary recall of heartburn medication ranitidine, including Zantac, after discovering the presence of a possible carcinogen.

This content has been archived. It is available through our partners, LexisNexis® and Bloomberg Law.

To view this content, please continue to their sites.

Not a Lexis Subscriber?
Subscribe Now

Not a Bloomberg Law Subscriber?
Subscribe Now

Why am I seeing this?

LexisNexis® and Bloomberg Law are third party online distributors of the broad collection of current and archived versions of ALM's legal news publications. LexisNexis® and Bloomberg Law customers are able to access and use ALM's content, including content from the National Law Journal, The American Lawyer, Legaltech News, The New York Law Journal, and Corporate Counsel, as well as other sources of legal information.

For questions call 1-877-256-2472 or contact us at [email protected]